Cargando…
Blood Tests for Alzheimer’s Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance
The recent academic and commercial development, and regulatory approvals, of blood-based Alzheimer’s disease (AD) biomarkers are breakthrough developments of immense potential. However, clinical validation studies and therapeutic trial applications are limited almost exclusively to non-Hispanic Whit...
Autor principal: | Karikari, Thomas K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741736/ https://www.ncbi.nlm.nih.gov/pubmed/35491788 http://dx.doi.org/10.3233/JAD-215730 |
Ejemplares similares
-
Strengthening Global Efforts to Combat Organ Trafficking and Transplant Tourism: Implications of the 2018 Edition of the Declaration of Istanbul
por: Martin, Dominique E., et al.
Publicado: (2019) -
Reconsidering ‘minimal risk’ to expand the repertoire of trials with waiver of informed consent for research
por: Monach, Paul A, et al.
Publicado: (2021) -
Self-directed multimedia process for delivering participant informed consent
por: Chapman, Niamh, et al.
Publicado: (2020) -
2171: Satisfaction and perceptions of research participants in Clinical and Translational Studies
por: Otado, Jane A., et al.
Publicado: (2018) -
Qualitative study of GPs’ views and experiences of population-based preconception expanded carrier screening in the Netherlands: bioethical perspectives
por: Morberg Jämterud, Sofia, et al.
Publicado: (2021)